The RELIEF™ Ureteral Stent Randomized Controlled Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Kidney Stone
Interventions
DEVICE

RELIEF Ureteral Stent

The study intervention is placement of the RELIEF Ureteral Stent

DEVICE

Standard of Care Ureteral Stent

The control product is the Ascerta stent by Boston Scientific.

All Listed Sponsors
collaborator

The Ureteral Stent Company

UNKNOWN

lead

University of California, San Diego

OTHER

NCT06720740 - The RELIEF™ Ureteral Stent Randomized Controlled Trial | Biotech Hunter | Biotech Hunter